Zimmer Biomet price target lowered to $113 from $118 at Truist
Truist analyst Richard Newitter lowered the firm’s price target on Zimmer Biomet (ZBH) to $113 from $118 and keeps a Hold rating on the shares.
Zimmer Biomet Holdings (ZBH) Receives a Buy from BTIG
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...
Yahoo Finance5d
Zimmer Biomet (ZBH) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company Zimmer Biomet (NYSE:ZBH) will be reporting earnings tomorrow before market hours. Here’s what investors should know. Zimmer Biomet beat analysts’ revenue expectations by ...